Skip to content

An exploratory study on the improvement of cognitive impairment with optical stimulation smart glasses

An exploratory study on the improvement of cognitive impairment with optical stimulation smart glasses

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071558
Enrollment
Unknown
Registered
2023-05-18
Start date
2023-02-05
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Congitive Impairment

Interventions

MCI Experimental group:Photoacoustic stimulation
MCI Control group:Sham stimulation
Healthy Experimental group:Photoacoustic stimulation
Healthy Control group:Sham stimulation

Sponsors

The 2nd Affiliated Hospital of Zhejiang University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients: 1. Aged 50-80 years old 2. Diagnosed with MCI according to Petersen diagnostic criteria 3. Minimum Mental State Examination (MMSE) score between 17 and 22 4. Geriatric Depression Scale Brief (GDS-15) GDS = 5 5. No visual or auditory pathology to allow scale monitoring 6. = 5 years of education and able to complete normal communication 7. If taking medication, ensure that it is stable for at least 3 months 8. Understand the procedure and protocol and sign a written informed consent form Healthy people: 1. Aged 18-85 years old 2. No visual or auditory abnormalities, capable of completing scale monitoring 3. = 5 years of education and able to complete normal communication 4. Understand the procedure and protocol and sign a written informed consent form

Exclusion criteria

Exclusion criteria: 1. Left-handed 2. People who cannot tolerate or have contraindications for MRI scanning 3. Individuals with severe eye diseases such as glaucoma and cataracts 4. Patients with mental/neurological disorders such as mania and epilepsy 5. Participation in other trials within the last 3 months (including memory clinics, online cognitive games, etc.) 6. Have received other internal medication for the condition prior to consultation: within 3 months of screening, have received the following medications: memantine, stilbestrol, donepezil, galantamine carbamate or other experimental medications 7. If the answer to any of the above is "yes", the subject will not be allowed to enter the study

Design outcomes

Primary

MeasureTime frame
Magnetic resonance imaging scanning (MRI);Mini-mental state examination (MMSE);

Secondary

MeasureTime frame
Pittsburgh sleep quality index (PSQI);Electroencephalogram (EEG);Alzheimer’s Disease Assessment Scale – Cognitive Subscale (ADAS-Cog);Geriatric Depression Scale (GDS);Activity of Daily Living Scale (ADL);

Countries

China

Contacts

Public ContactZhang Minming

The 2nd Affiliated Hospital of Zhejiang University, School of Medicine

zhangminming@zju.edu.cn+86 139 0652 0711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026